Atara Biotherapeutics (ATRA) Live Share Price, Invest From India

Atara Biotherapeutics Stock Performance

as on September 15, 2026 at 2:15 pm IST

Day's Low
Day's High
$9.07
Day's Price Range
$9.71
$9.25
1.95%
Downside
4.97%
Upside
52 Week's Low
52 Week's High
$3.92
52-Week Price Range
$19.15
$9.25
57.62%
Downside
106.97%
Upside

Atara Biotherapeutics share price movements today

Previous Close: $9.38
Open: $9.09
Volume: 113.9K
Market Cap: $94.2M
Day's Low - High: $9.07 - $9.71
52 Week Low - High: $3.92 - $19.15

Atara Biotherapeutics Historical Returns

1 Month Return: + 15.95 %
3 Month Return: -9.89 %
1 Year Return: -22.61 %
3 Year Return: -75.48 %
5 Year Return: -97.6 %

Atara Biotherapeutics Stock Fundamentals & Key Indicators

Check Atara Biotherapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$94.2M

EPS (TTM)

-0.95

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-11.1M

Revenue (TTM)

6.2M

Profit Margin

-269.42%

Return On Equity TTM

-2014.86%

Atara Biotherapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Atara Biotherapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Atara Biotherapeutics	BUY	$94.2M	-97.6%	NA	-269.42%	NA
Revolution Medicines	BUY	$44.6B	614.61%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$130.6B	173.57%	29.76	86.04%	NA
Moderna	BUY	$57.5B	-66.34%	-18.04	-12.57%	NA
Regeneron	BUY	$80.5B	21.13%	18.66	84.86%	47.339999999999996%

Stock Returns calculator for Atara Biotherapeutics Stock including INR - Dollar returns

The Atara Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Atara Biotherapeutics investment value today

Current value as on today

₹82,745

Returns

-₹17,255

(-17.26%)

Returns from Atara Biotherapeutics Stock

-₹23,680 (-23.68%)

Dollar Impact

₹6,425 (+6.42%)

Analyst Recommendation on Atara Biotherapeutics Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Atara Biotherapeutics. Average target price of $13.67

Atara Biotherapeutics Share Price Target

Get share price movements and forecasts by analysts on Atara Biotherapeutics.

What analysts predicted

32.33%UPSIDE

Target Price

$13.67

Current Price

$9.25

Analyzed by

2 Analysts

Target

$13.67

Atara Biotherapeutics target price $13.67, a slight upside of 32.33% compared to current price of $9.25. According to 2 analysts rating.

Atara Biotherapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	27	28	40	32	98	17	3	1	0	0
Gross Profit	25	24	32	25	77	17	3	1	0	0
Operating Income	-31	-18	-21	-12	38	3	-3	-2	-3	-4
EBITDA	-29	-16	-19	-10	40	3	-3	-2	-3	-4
Interest Expense	1	1	1	1	1	0	0	0	0	0
Depreciation	1	1	1	1	1	0	0	0	0	0
Income Before Tax	-31	-19	-21	-12	38	2	-4	-3	-4	-4
Income Tax Expense	0	171	0	0	-	0	0	-	-	0
Net Income	-31	-19	-21	-12	38	2	-4	-3	-4	-4
Net Profit Margin	-116.07%	-66.51%	-54.51%	-38.75%	38.73%	13.58%	-124.62%	-213.54%	-803.29%	-767.30%

Atara Biotherapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	3	20	63	8	128	120
Gross Profit	0	0	-3	-8	-9	20	-206	0	107	99
Operating Income	-81	-121	-237	-295	-309	-340	-280	-276	-83	35
EBITDA	-80	-120	-233	-288	-300	-331	-222	-265	-75	38
Interest Expense	-	-	-	11	10	9	0	5	4	3
Depreciation	-	0	3	7	8	9	5	4	5	2
Income Before Tax	-79	-119	-230	-290	-306	-340	-228	-276	-85	32
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-79	-119	-230	-290	-306	-340	-228	-276	-85	32
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-8632.32%	-1672.28%	-359.12%	-3220.88%	-66.23%	27.07%

Atara Biotherapeutics Quarterly Cash Flow

All numbers in Millions USD

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-19	-21	-12	38	2	-4	-3	-4	-4
Operating Cash Flow	-10	-3	-24	-28	-7	-9	-5	-3	-3
Investing Cash Flow	7	-16	3	17	-5	-2	8	-	-6
Financing Cash Flow	0	35	0	0	15	1	0	2	4
Change in Cash	-3	15	-21	-11	2	-11	2	0	-5

Atara Biotherapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-119	-230	-290	-306	-340	-228	-276	-85	32
Operating Cash Flow	-87	-179	-235	-180	-220	-270	-192	-68	-50
Investing Cash Flow	98	-196	60	-120	22	202	123	8	18
Financing Cash Flow	20	357	188	427	103	53	2	59	16
Change in Cash	31	-18	13	126	-94	-14	-67	0	-16

Mutual Funds that own Atara Biotherapeutics Stock

Check out the Mutual Funds with significant holdings in Atara Biotherapeutics.

Funds	Holdings	Shares Held
VANGUARD INDEX FUNDS	2.142102%	215018
Fidelity Commonwealth Trust II	1.413908%	141924
Fidelity Concord Street Trust	0.505473%	50738
Bridgeway Funds, Inc.	0.325681%	32691
Northern Funds	0.318917%	32012

See all

Global Institutional Holdings in Atara Biotherapeutics

Funds	Holdings
Vanguard	2.4%
iShares	0.19%
Bridgeway	0.14%
Dimensional	0%

Insights on Atara Biotherapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 516.0K → 630.0K (in $), with an average increase of 18.1% per quarter
POSITIVE IMPACT
Price Rise
In the last 1 month, ATRA stock has moved up by 14.3%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 514.3% return, outperforming this stock by 536.8%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 28.0% return, outperforming this stock by 103.8%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -3.40M → -4.83M (in $), with an average decrease of 19.2% per quarter

About Atara Biotherapeutics

Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and internationally. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) with post-transplant lymphoproliferative disease, as well as other EBV-driven diseases. It also develops ATA3219, an allogeneic CAR T targeting CD19 intended to target B-cell malignancies and autoimmune diseases. The company has research collaboration agreements with Memorial Sloan Kettering Cancer Center, and Council of the Queensland Institute of Medical Research. Atara Biotherapeutics, Inc. was incorporated in 2012 and is headquartered in Thousand Oaks, California.

Organisation	Atara Biotherapeutics
Headquarters	1280 Rancho Conejo Blvd, Thousand Oaks, CA, United States, 91320
Industry	Biotechnology
CEO	Dr. Anhco Nguyen Ph.D.
E-voting on shares	Click here to vote

Key Management of Atara Biotherapeutics

Name	Title
Dr. Anhco Nguyen Ph.D.	President, CEO & Director
Mr. Kevin G. Sarney CPA	Interim Chief Financial Officer
Mr. Jim Sesic	Senior Vice President of Regulatory Affairs

FAQs

What is Atara Biotherapeutics share price today?

Atara Biotherapeutics share price today is $9.25 as on September 15, 2026 at 8:45 am IST at the close of the market. Atara Biotherapeutics share today touched a day high of $9.71 and a low of $9.07.

What is the 52 week high and 52 week low for Atara Biotherapeutics share?

Atara Biotherapeutics share touched a 52 week high of $19.15 on January 5, 2026 and a 52 week low of $3.92 on February 23, 2026. Atara Biotherapeutics stock price today i.e. September 15, 2026 at 8:45 am IST is closed at $9.25,which is 51.68% down from its 52 week high and 135.97% up from its 52 week low.

What is Atara Biotherapeutics's market capitalisation today?

Atara Biotherapeutics market capitalisation is $0.00T as on September 15, 2026 at 8:45 am IST.

How to invest in Atara Biotherapeutics Stock (ATRA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Atara Biotherapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Atara Biotherapeutics Shares that will get you 0.1622 shares as per Atara Biotherapeutics share price of $9.25 per share as on September 15, 2026 at 8:45 am IST.

What is the minimum amount required to buy Atara Biotherapeutics Stock (ATRA) from India?

Indian investors can start investing in Atara Biotherapeutics (ATRA) shares with as little as ₹95.54 or $1 (as of September 15, 2026 at 12:47 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹955.40 in Atara Biotherapeutics stock (as per the Rupee-Dollar exchange rate as on September 15, 2026 at 12:47 pm IST). Based on Atara Biotherapeutics share’s latest price of $9.25 as on September 15, 2026 at 8:45 am IST, you will get 1.0811 shares of Atara Biotherapeutics. Learn more about fractional shares .

What are the returns that Atara Biotherapeutics has given to Indian investors in the last 5 years?

Atara Biotherapeutics stock has given -97.6% share price returns and 29.75% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?